Annual CFI
-$55.77 M
+$154.73 M+73.51%
31 December 2023
Summary:
GoodRx Holdings annual cash flow from investing activities is currently -$55.77 million, with the most recent change of +$154.73 million (+73.51%) on 31 December 2023. During the last 3 years, it has risen by +$35.85 million (+39.13%). GDRX annual CFI is now -1512.67% below its all-time high of -$3.46 million, reached on 31 December 2018.GDRX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$15.86 M
+$1.37 M+7.95%
30 September 2024
Summary:
GoodRx Holdings quarterly cash flow from investing activities is currently -$15.86 million, with the most recent change of +$1.37 million (+7.95%) on 30 September 2024. Over the past year, it has dropped by -$2.21 million (-16.21%). GDRX quarterly CFI is now -1333.20% below its all-time high of $1.29 million, reached on 31 December 2022.GDRX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$66.58 M
-$2.21 M-3.44%
30 September 2024
Summary:
GoodRx Holdings TTM cash flow from investing activities is currently -$66.58 million, with the most recent change of -$2.21 million (-3.44%) on 30 September 2024. Over the past year, it has dropped by -$24.97 million (-60.01%). GDRX TTM CFI is now -1854.07% below its all-time high of -$3.41 million, reached on 31 March 2020.GDRX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GDRX Cash From Investing Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +73.5% | -16.2% | -60.0% |
3 y3 years | +39.1% | +41.4% | +62.9% |
5 y5 years | -1512.7% | - | - |
GDRX Cash From Investing High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +73.5% | -1333.2% | +90.3% | -60.0% | +71.6% |
5 y | 5 years | -1512.7% | +73.5% | -1333.2% | +90.3% | -1854.1% | +71.6% |
alltime | all time | -1512.7% | +73.5% | -1333.2% | +90.3% | -1854.1% | +71.6% |
GoodRx Holdings Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$15.86 M(-8.0%) | -$66.58 M(+3.4%) |
June 2024 | - | -$17.23 M(-16.4%) | -$64.36 M(+3.7%) |
Mar 2024 | - | -$20.61 M(+60.2%) | -$62.09 M(+11.3%) |
Dec 2023 | -$55.77 M(-73.5%) | -$12.87 M(-5.7%) | -$55.77 M(+34.0%) |
Sept 2023 | - | -$13.65 M(-8.8%) | -$41.61 M(-0.3%) |
June 2023 | - | -$14.96 M(+4.7%) | -$41.74 M(-78.1%) |
Mar 2023 | - | -$14.29 M(-1211.0%) | -$190.38 M(-9.6%) |
Dec 2022 | -$210.50 M | $1.29 M(-109.3%) | -$210.50 M(-4.8%) |
Sept 2022 | - | -$13.78 M(-91.6%) | -$221.04 M(-5.7%) |
June 2022 | - | -$163.61 M(+375.6%) | -$234.33 M(+15.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$34.40 M(+271.5%) | -$203.44 M(+13.8%) |
Dec 2021 | -$178.73 M(+95.1%) | -$9.26 M(-65.8%) | -$178.73 M(-0.3%) |
Sept 2021 | - | -$27.06 M(-79.6%) | -$179.28 M(-20.6%) |
June 2021 | - | -$132.72 M(+1269.0%) | -$225.71 M(+130.5%) |
Mar 2021 | - | -$9.70 M(-1.2%) | -$97.91 M(+6.9%) |
Dec 2020 | -$91.62 M(+147.2%) | -$9.81 M(-86.7%) | -$91.62 M(+12.0%) |
Sept 2020 | - | -$73.49 M(+1396.1%) | -$81.81 M(+883.4%) |
June 2020 | - | -$4.91 M(+44.2%) | -$8.32 M(+144.2%) |
Mar 2020 | - | -$3.41 M | -$3.41 M |
Dec 2019 | -$37.05 M(+971.6%) | - | - |
Dec 2018 | -$3.46 M | - | - |
FAQ
- What is GoodRx Holdings annual cash flow from investing activities?
- What is the all time high annual CFI for GoodRx Holdings?
- What is GoodRx Holdings annual CFI year-on-year change?
- What is GoodRx Holdings quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for GoodRx Holdings?
- What is GoodRx Holdings quarterly CFI year-on-year change?
- What is GoodRx Holdings TTM cash flow from investing activities?
- What is the all time high TTM CFI for GoodRx Holdings?
- What is GoodRx Holdings TTM CFI year-on-year change?
What is GoodRx Holdings annual cash flow from investing activities?
The current annual CFI of GDRX is -$55.77 M
What is the all time high annual CFI for GoodRx Holdings?
GoodRx Holdings all-time high annual cash flow from investing activities is -$3.46 M
What is GoodRx Holdings annual CFI year-on-year change?
Over the past year, GDRX annual cash flow from investing activities has changed by +$154.73 M (+73.51%)
What is GoodRx Holdings quarterly cash flow from investing activities?
The current quarterly CFI of GDRX is -$15.86 M
What is the all time high quarterly CFI for GoodRx Holdings?
GoodRx Holdings all-time high quarterly cash flow from investing activities is $1.29 M
What is GoodRx Holdings quarterly CFI year-on-year change?
Over the past year, GDRX quarterly cash flow from investing activities has changed by -$2.21 M (-16.21%)
What is GoodRx Holdings TTM cash flow from investing activities?
The current TTM CFI of GDRX is -$66.58 M
What is the all time high TTM CFI for GoodRx Holdings?
GoodRx Holdings all-time high TTM cash flow from investing activities is -$3.41 M
What is GoodRx Holdings TTM CFI year-on-year change?
Over the past year, GDRX TTM cash flow from investing activities has changed by -$24.97 M (-60.01%)